Chemotherapy reshapes cellular clonal landscape via persister programs in breast cancer xenografts
Kronheim, S.; Wang, J.; Chen, J. Y.; Guerrero-Romero, D.; Chin, S.-F.; Lerda, G.; Lui, A. J. W.; Rueda, O. M.; Gaiti, F.; Caldas, C.; Nguyen, L. V.
Show abstract
Tumor ecosystems evolve in response to chemotherapy, but how treatment reshapes clonal architecture and the transcriptional programs of distinct cell states remains unclear. To investigate the response to chemotherapy by individual single cell-derived clones, we used a high-complexity lentiviral barcoding strategy by genetically labelling with unique, heritable and expressible barcode sequences individual cells from four human breast cancer patient-derived tumor xenograft models. We tracked 3,248 single cell-derived clones across 39 xenografts and profiled 676,292 cells with single cell RNA sequencing. The most striking changes following chemotherapy occurred in non-responsive xenografts, attributed to the emergence of previously minor cell clones that are chemotherapy resistant. In a triple negative model, epithelial and mesenchymal cell states showed distinct sensitivities to chemotherapy. ER+/HER2-models activated stress adaptive programs in response to carboplatin, highlighting DUSP1 and KLF4 as markers of platinum tolerance and a slow cycling, persister-like state. Together, these findings reveal that chemotherapy triggers an immediate and substantial reorganization of the cellular clonal landscape, driven by the selective engagement of stress response programs in cell clones that survive treatment.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Adaptation and Selection Shape Clonal Evolution During Residual Disease and Recurrence 96%
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 96%
- GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer 96%
Similar papers in this journal
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
- Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations 95%
- Combined KRASG12C and SOS1 inhibition enhances and extends the anti-tumor response in KRASG12C-driven cancers by addressing intrinsic and acquired resistance 95%
Similar papers in this journal
- Spatiotemporal profiling defines persistence and resistance dynamics during targeted treatment of melanoma 97%
- Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenografts 95%
- Neoplastic immune mimicry potentiates breast tumor progression 95%
Similar papers in this journal
- Evolutionary states and trajectories characterized by distinct pathways stratify ovarian high-grade serous carcinoma patients 96%
- Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer 96%
- B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.